← All tickers

Is BCRX Worth Buying in 2026?

BioCryst Pharmaceuticals Inc

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-07-26

Here’s whether BioCryst Pharmaceuticals Inc (BCRX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.07% over 10 days); RSI 39 — healthy momentum range. Concerns: declining volume on rally — weak conviction (0.58x 30d avg). Currently 16.8% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

BCRX is in a confirmed uptrend, trading above both its 50-day ($9.24) and 200-day ($8.18) moving averages. An RSI of 39.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +9.2% compares to +16.5% for SPY (trailed the market by 7.2%).

$10,000 invested 1 year ago → $10,924 today
vs. S&P 500 (SPY) — same period trailed market by 7.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($8.18)
✓Above 50-day MA ($9.24)
✓RSI(14) neutral zone (30–70) — currently 39.3
✓Positive return (+9.2%)
!Within 10% of period high (−16.8%)
Period Range $9.34
$6.00 $11.22
RSI (14) 39.3
0 · OversoldOverbought · 100

Key Metrics

Price$9.34
Period Return+9.2%
Period High$11.22
Period Low$6.00
Drawdown−16.8%
MA-50$9.24
MA-200$8.18
RSI (14)39.3
Avg Volume (30d)5.4M
vs. SPYtrailed by 7.2%
Return Rank#451 of 999

Trade BCRX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers